Literature DB >> 18546003

Exploiting biology in selecting treatment for differentiated cancer of the thyroid gland.

Jatin P Shah1.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18546003     DOI： 10.1007/s00405-008-0728-3

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN： 0937-4477            Impact factor:   2.503


× No keyword cloud information.
  19 in total

1.  Epidemiology of head and neck cancer in the United States.

Authors:  Louise Davies; H Gilbert Welch
Journal:  Otolaryngol Head Neck Surg       Date:  2006-09       Impact factor: 3.497

Review 2.  Poorly differentiated thyroid carcinoma: introduction to the issue, its landmarks, and clinical impact.

Authors:  Juan Rosai
Journal:  Endocr Pathol       Date:  2004       Impact factor: 3.943

3.  Management guidelines for patients with thyroid nodules and differentiated thyroid cancer.

Authors:  David S Cooper; Gerard M Doherty; Bryan R Haugen; Richard T Kloos; Stephanie L Lee; Susan J Mandel; Ernest L Mazzaferri; Bryan McIver; Steven I Sherman; R Michael Tuttle
Journal:  Thyroid       Date:  2006-02       Impact factor: 6.568

4.  Increasing incidence of thyroid cancer in the United States, 1973-2002.

Authors:  Louise Davies; H Gilbert Welch
Journal:  JAMA       Date:  2006-05-10       Impact factor: 56.272

5.  Lobectomy versus total thyroidectomy for differentiated carcinoma of the thyroid: a matched-pair analysis.

Authors:  J P Shah; T R Loree; D Dharker; E W Strong
Journal:  Am J Surg       Date:  1993-10       Impact factor: 2.565

6.  Papillary thyroid carcinoma managed at the Mayo Clinic during six decades (1940-1999): temporal trends in initial therapy and long-term outcome in 2444 consecutively treated patients.

Authors:  Ian D Hay; Geoffrey B Thompson; Clive S Grant; Eric J Bergstralh; Catherine E Dvorak; Colum A Gorman; Megan S Maurer; Bryan McIver; Brian P Mullan; Ann L Oberg; Claudia C Powell; Jon A van Heerden; John R Goellner
Journal:  World J Surg       Date:  2002-05-21       Impact factor: 3.352

7.  A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995 [see commetns].

Authors:  S A Hundahl; I D Fleming; A M Fremgen; H R Menck
Journal:  Cancer       Date:  1998-12-15       Impact factor: 6.860

8.  Locally invasive papillary thyroid carcinoma: 1940-1990.

Authors:  T V McCaffrey; E J Bergstralh; I D Hay
Journal:  Head Neck       Date:  1994 Mar-Apr       Impact factor: 3.147

9.  Undifferentiated and poorly differentiated carcinoma.

Authors:  J Rosai; E A Saxén; L Woolner
Journal:  Semin Diagn Pathol       Date:  1985-05       Impact factor: 3.464

10.  Differentiated carcinoma of the thyroid with extrathyroidal extension.

Authors:  P E Andersen; J Kinsella; T R Loree; A R Shaha; J P Shah
Journal:  Am J Surg       Date:  1995-11       Impact factor: 2.565
View more
  2 in total

1.  Surgical decision making in the management of well-differentiated thyroid cancer.

Authors:  Natalya Chernichenko; Ashok R Shaha
Journal:  Indian J Surg Oncol       Date:  2012-05-01

2.  Estimating risk of recurrence in differentiated thyroid cancer after total thyroidectomy and radioactive iodine remnant ablation: using response to therapy variables to modify the initial risk estimates predicted by the new American Thyroid Association staging system.

Authors:  R Michael Tuttle; Hernan Tala; Jatin Shah; Rebecca Leboeuf; Ronald Ghossein; Mithat Gonen; Matvey Brokhin; Gal Omry; James A Fagin; Ashok Shaha
Journal:  Thyroid       Date:  2010-10-29       Impact factor: 6.568
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.